References
- Yang J, Wu H, Zhang P, Hou DM, Chen J, Zhang SG. The pharmacokinetic profiles of dexamethasone and methylprednisolone concentration in perilymph and plasma following systemic and local administration. Acta Otolaryngol 2007; Oct 4:1–9 [Epub ahead of print].
- Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007; 28: 1124–30
- Kilic R, Safak MA, Oguz H, Kargin S, Demirci M, Samim E, et al. Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol 2007; 28: 312–16
- Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2007; Aug 22:1–4 [Epub ahead of print].
- Dodson KM, Woodson E, Sismanis A. Intratympanic steroid perfusion for the treatment of Meniere's disease: a retrospective study. Ear Nose Throat J 2004; 83: 394–8
- Fukushima M, Kitahara T, Uno Y, Fuse Y, Doi K, Kubo T. Effects of intratympanic injection of steroids on changes in rat inner ear aquaporin expression. Acta Otolaryngol 2002; 122: 600–6
- Sone M, Hayashi H, Yamamoto H, Tominaga M, Nakashima T. A comparative study of intratympanic steroid and NO synthase inhibitor for treatment of cochlear lateral wall damage due to acute otitis media. Eur J Pharmacol 2003; 482: 313–18
- Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998; 19: 230–5
- Heinonen K, Fedinec A, Leffler CW. Dexamethasone pretreatment attenuates cerebral vasodilative responses to hypercapnia and augments vasoconstrictive responses to hyperventilation in newborn pigs. Pediatr Res 2003; 53: 260–5
- Akdemir G, Ergungor MF, Sezer M, Albayrak L, Daglioglu E, Kilinc K. Therapeutic efficacy of intraventricular cyclosporine A and methylprednisolone on a global cerebral ischemia model in rats. Neurol Res 2005; 27: 827–34
- Slivka AP, Murphy EJ. High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp Neurol 2001; 167: 166–72
- Nakashima T, Suzuki T, Iwagaki T, Hibi T. Effects of anterior inferior cerebellar artery occlusion on cochlear blood flow – a comparison between laser-Doppler and microsphere methods. Hear Res 2001; 162: 85–90
- Cummins EP, Comerford KM, Scholz C, Bruning U, Taylor CT. Hypoxic regulation of NF-kappaB signaling. Methods Enzymol 2007; 435: 479–92
- Ruas JL, Lendahl U, Poellinger L. Modulation of vascular gene expression by hypoxia. Curr Opin Lipidol 2007; 18: 508–14
- Frede S, Berchner-Pfannschmidt U, Fandrey J. Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol 2007; 435: 405–19
- Leonard MO, Godson C, Brady HR, Taylor CT. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol 2005; 174: 2250–7
- Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006; 27: 564–9
- Nakashima T, Naganawa S, Sone M, Tominaga M, Hayashi H, Yamamoto H, et al. Disorders of cochlear blood flow. Brain Res Brain Res Rev 2003; 43: 17–28
- Ren T, Nuttall AL, Miller JM. Contribution of the anterior inferior cerebellar artery to cochlear blood flow in guinea pig: a model-based analysis. Hear Res 1993; 71: 91–7
- Tabuchi K, Oikawa K, Murashita H, Hoshino T, Tsuji S, Hara A. Protective effects of glucocorticoids on ischemia-reperfusion injury of outer hair cells. Laryngoscope 2006; 116: 627–9